O	O	0	9	Infection	Infection	B-NP	NN	O	3	NMOD	O
O	O	10	13	and	and	I-NP	CC	O	3	NMOD	O
O	O	14	25	replication	replication	I-NP	NN	O	12	NMOD	O
O	O	26	28	of	of	B-PP	IN	O	3	NMOD	O
T1	B-Protein	29	32	Tat	Tat	B-NP	NN	B-protein	9	NMOD	B-protein
O	O	32	33	-	-	O	HYPH	O	9	P	O
O	O	34	39	human	human	B-NP	JJ	O	9	NMOD	O
O	O	40	56	immunodeficiency	immunodeficiency	I-NP	NN	O	9	NMOD	O
O	O	57	64	viruses	virus	I-NP	NNS	O	4	PMOD	O
O	O	64	65	:	:	O	:	O	3	P	O
O	O	66	73	genetic	genetic	B-NP	JJ	O	12	NMOD	O
O	O	74	82	analyses	analysis	I-NP	NNS	O	0	ROOT	O
O	O	83	85	of	of	B-PP	IN	O	12	NMOD	O
T18	B-Entity	86	89	LTR	LTR	B-NP	NN	B-DNA	17	NMOD	B-DNA
O	O	90	93	and	and	I-NP	CC	O	17	NMOD	O
T2	B-Protein	94	97	tat	tat	I-NP	NN	B-protein	17	NMOD	B-protein
O	O	98	107	mutations	mutation	I-NP	NNS	I-protein	13	PMOD	I-protein
O	O	108	110	in	in	B-PP	IN	O	17	NMOD	O
O	O	111	118	primary	primary	B-NP	JJ	B-cell_type	26	NMOD	B-cell_type
O	O	119	122	and	and	I-NP	CC	I-cell_type	26	NMOD	I-cell_type
O	O	123	127	long	long	I-NP	JJ	I-cell_type	26	NMOD	I-cell_type
O	O	127	128	-	-	I-NP	HYPH	I-cell_type	26	NMOD	I-cell_type
O	O	128	132	term	term	I-NP	NN	I-cell_type	26	NMOD	I-cell_type
O	O	133	138	human	human	I-NP	JJ	I-cell_type	26	NMOD	I-cell_type
O	O	139	147	lymphoid	lymphoid	I-NP	JJ	I-cell_type	26	NMOD	I-cell_type
O	O	148	153	cells	cell	I-NP	NNS	I-cell_type	18	PMOD	I-cell_type
O	O	153	154	.	.	O	.	O	12	P	O

T3	B-Protein	156	159	Tat	Tat	B-NP	NN	B-protein	2	SUB	B-protein
O	O	160	162	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	163	165	an	an	B-NP	DT	O	4	NMOD	O
O	O	166	175	essential	essential	I-NP	JJ	O	2	PRD	O
O	O	176	186	regulatory	regulatory	I-NP	JJ	B-protein	6	NMOD	B-protein
O	O	187	194	protein	protein	I-NP	NN	I-protein	4	NMOD	I-protein
O	O	195	198	for	for	B-PP	IN	O	4	NMOD	O
O	O	199	202	the	the	B-NP	DT	O	9	NMOD	O
O	O	203	214	replication	replication	I-NP	NN	O	7	PMOD	O
O	O	215	217	of	of	B-PP	IN	O	9	NMOD	O
O	O	218	223	human	human	B-NP	JJ	O	13	NMOD	O
O	O	224	240	immunodeficiency	immunodeficiency	I-NP	NN	O	13	NMOD	O
O	O	241	246	virus	virus	I-NP	NN	O	10	PMOD	O
O	O	247	248	(	(	O	(	O	16	DEP	O
O	O	248	251	HIV	HIV	B-NP	NN	O	16	DEP	O
O	O	251	252	)	)	O	)	O	13	NMOD	O
O	O	252	253	.	.	O	.	O	2	P	O

O	O	254	263	Mutations	Mutation	B-NP	NNS	O	6	SUB	O
O	O	264	266	in	in	B-PP	IN	O	1	NMOD	O
O	O	267	270	the	the	B-NP	DT	O	5	NMOD	O
T4	B-Protein	271	274	tat	tat	I-NP	NN	B-DNA	5	NMOD	B-DNA
O	O	275	279	gene	gene	I-NP	NN	I-DNA	2	PMOD	I-DNA
O	O	280	284	have	have	B-VP	VBP	O	0	ROOT	O
O	O	285	289	been	be	I-VP	VBN	O	6	VC	O
O	O	290	295	shown	show	I-VP	VBN	O	7	VC	O
O	O	296	298	to	to	I-VP	TO	O	10	VMOD	O
O	O	299	304	block	block	I-VP	VB	O	8	VMOD	O
O	O	305	308	HIV	HIV	B-NP	NN	O	12	NMOD	O
O	O	309	320	replication	replication	I-NP	NN	O	10	OBJ	O
O	O	321	323	in	in	B-PP	IN	O	12	NMOD	O
O	O	324	329	human	human	B-NP	JJ	B-cell_type	16	NMOD	B-cell_type
O	O	330	331	T	T	I-NP	NN	I-cell_type	16	NMOD	I-cell_type
O	O	332	337	cells	cell	I-NP	NNS	I-cell_type	13	PMOD	I-cell_type
O	O	337	338	.	.	O	.	O	6	P	O

O	O	339	346	Several	Several	B-NP	JJ	O	2	NMOD	O
O	O	347	354	studies	study	I-NP	NNS	O	3	SUB	O
O	O	355	359	have	have	B-VP	VBP	O	26	VMOD	O
O	O	360	371	established	establish	I-VP	VBN	O	3	VC	O
O	O	372	376	that	that	B-SBAR	IN	O	4	VMOD	O
T5	B-Protein	377	380	Tat	Tat	B-NP	NN	B-protein	7	SUB	B-protein
O	O	381	389	releases	release	B-VP	VBZ	O	5	SBAR	O
O	O	390	392	an	an	B-NP	DT	O	10	NMOD	O
O	O	393	403	elongation	elongation	I-NP	NN	B-protein	10	NMOD	B-protein
O	O	404	409	block	block	I-NP	NN	I-protein	7	OBJ	I-protein
O	O	410	412	to	to	B-PP	TO	O	10	NMOD	O
O	O	413	416	the	the	B-NP	DT	O	13	NMOD	O
O	O	417	430	transcription	transcription	I-NP	NN	O	11	PMOD	O
O	O	431	433	of	of	B-PP	IN	O	13	NMOD	O
T19	B-Entity	434	437	HIV	HIV	B-NP	NN	B-DNA	18	NMOD	B-DNA
T19	I-Entity	438	442	long	long	I-NP	JJ	I-DNA	18	NMOD	I-DNA
T19	I-Entity	443	451	terminal	terminal	I-NP	JJ	I-DNA	18	NMOD	I-DNA
T19	I-Entity	452	458	repeat	repeat	I-NP	NN	I-DNA	14	PMOD	I-DNA
O	O	459	460	(	(	O	(	O	21	DEP	O
T20	B-Entity	460	463	LTR	LTR	B-NP	NN	B-DNA	21	DEP	B-DNA
O	O	463	464	)	)	O	)	O	18	NMOD	O
O	O	464	465	;	;	O	:	O	26	P	O
O	O	466	473	however	however	B-ADVP	RB	O	26	VMOD	O
O	O	473	474	,	,	O	,	O	26	P	O
O	O	475	477	it	it	B-NP	PRP	O	26	SUB	O
O	O	478	480	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	481	484	not	not	I-VP	RB	O	26	VMOD	O
O	O	485	490	known	know	I-VP	VBN	O	26	VC	O
O	O	491	498	whether	whether	B-SBAR	IN	O	28	VMOD	O
O	O	499	503	this	this	B-NP	DT	O	31	NMOD	O
O	O	504	513	mechanism	mechanism	I-NP	NN	O	33	SUB	O
O	O	514	519	alone	alone	B-ADVP	RB	O	31	NMOD	O
O	O	520	522	is	be	B-VP	VBZ	O	29	SBAR	O
O	O	523	533	sufficient	sufficient	B-ADJP	JJ	O	33	PRD	O
O	O	534	536	to	to	B-VP	TO	O	36	VMOD	O
O	O	537	544	explain	explain	I-VP	VB	O	33	VMOD	O
O	O	545	548	the	the	B-NP	DT	O	38	NMOD	O
O	O	549	554	block	block	I-NP	NN	O	36	OBJ	O
O	O	555	557	to	to	B-PP	TO	O	38	NMOD	O
O	O	558	561	HIV	HIV	B-NP	NN	O	41	NMOD	O
O	O	562	573	replication	replication	I-NP	NN	O	39	PMOD	O
O	O	574	576	in	in	B-PP	IN	O	41	NMOD	O
O	O	577	582	human	human	B-NP	JJ	B-cell_type	45	NMOD	B-cell_type
O	O	583	584	T	T	I-NP	NN	I-cell_type	45	NMOD	I-cell_type
O	O	585	590	cells	cell	I-NP	NNS	I-cell_type	42	PMOD	I-cell_type
O	O	591	595	when	when	B-ADVP	WRB	O	36	VMOD	O
T6	B-Protein	596	599	Tat	Tat	B-NP	NN	B-protein	48	SUB	B-protein
O	O	600	602	is	be	B-VP	VBZ	O	46	SBAR	O
O	O	603	609	absent	absent	B-ADJP	JJ	O	48	PRD	O
O	O	609	610	.	.	O	.	O	26	P	O

O	O	611	613	It	It	B-NP	PRP	O	2	SUB	O
O	O	614	616	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	617	625	possible	possible	B-ADJP	JJ	O	2	PRD	O
O	O	626	630	that	that	B-SBAR	IN	O	2	VMOD	O
T7	B-Protein	631	634	Tat	Tat	B-NP	NN	B-protein	6	SUB	B-protein
O	O	635	637	is	be	B-VP	VBZ	O	4	SBAR	O
O	O	638	642	also	also	I-VP	RB	O	6	VMOD	O
O	O	643	649	needed	need	I-VP	VBN	O	6	VC	O
O	O	650	653	for	for	B-PP	IN	O	8	VMOD	O
O	O	654	659	other	other	B-NP	JJ	O	11	NMOD	O
O	O	660	669	functions	function	I-NP	NNS	O	9	PMOD	O
O	O	670	676	during	during	B-PP	IN	O	8	VMOD	O
O	O	677	680	HIV	HIV	B-NP	NN	O	14	NMOD	O
O	O	681	692	replication	replication	I-NP	NN	O	12	PMOD	O
O	O	692	693	.	.	O	.	O	2	P	O

O	O	694	696	To	To	B-VP	TO	O	2	VMOD	O
O	O	697	701	test	test	I-VP	VB	O	7	VMOD	O
O	O	702	707	these	these	B-NP	DT	O	4	NMOD	O
O	O	708	718	hypotheses	hypothesis	I-NP	NNS	O	2	OBJ	O
O	O	718	719	,	,	O	,	O	7	P	O
O	O	720	722	we	we	B-NP	PRP	O	7	SUB	O
O	O	723	730	studied	study	B-VP	VBD	O	0	ROOT	O
O	O	731	738	several	several	B-NP	JJ	O	7	OBJ	O
T8	B-Protein	739	742	tat	tat	I-NP	NN	B-protein	10	NMOD	B-protein
O	O	743	750	mutants	mutant	I-NP	NNS	I-protein	8	NMOD	I-protein
O	O	750	751	,	,	O	,	O	8	P	O
O	O	752	761	including	include	B-PP	VBG	O	8	NMOD	O
O	O	762	765	two	two	B-NP	CD	O	18	NMOD	O
O	O	766	770	stop	stop	I-NP	NN	B-protein	16	NMOD	B-protein
O	O	771	776	codon	codon	I-NP	NN	I-protein	16	NMOD	I-protein
O	O	777	784	mutants	mutant	I-NP	NNS	I-protein	13	NMOD	I-protein
O	O	785	788	and	and	O	CC	O	18	NMOD	O
O	O	789	792	one	one	B-NP	CD	O	12	PMOD	O
O	O	793	801	deletion	deletion	I-NP	NN	B-DNA	20	NMOD	B-DNA
O	O	802	808	mutant	mutant	I-NP	NN	I-DNA	18	NMOD	I-DNA
O	O	809	814	using	use	B-VP	VBG	O	7	VMOD	O
T21	B-Entity	815	826	replication	replication	B-NP	NN	O	28	NMOD	O
T21	I-Entity	826	827	-	-	O	HYPH	O	28	P	O
T21	I-Entity	827	836	competent	competent	B-NP	JJ	O	25	NMOD	O
T21	I-Entity	837	840	HIV	HIV	I-NP	NN	O	28	NMOD	O
T21	I-Entity	840	841	-	-	B-NP	HYPH	O	28	NMOD	O
T21	I-Entity	841	842	1	1	I-NP	CD	B-DNA	28	NMOD	B-DNA
T21	I-Entity	843	853	constructs	construct	I-NP	NNS	I-DNA	21	OBJ	I-DNA
O	O	854	862	carrying	carry	B-VP	VBG	O	28	NMOD	O
O	O	863	867	wild	wild	B-NP	JJ	B-DNA	35	NMOD	B-DNA
O	O	867	868	-	-	I-NP	HYPH	I-DNA	35	P	I-DNA
O	O	868	872	type	type	I-NP	NN	I-DNA	35	NMOD	I-DNA
O	O	873	875	or	or	I-NP	CC	I-DNA	35	NMOD	I-DNA
O	O	876	882	mutant	mutant	I-NP	JJ	I-DNA	35	NMOD	I-DNA
T22	B-Entity	883	887	LTRs	LTR	I-NP	NNS	I-DNA	29	OBJ	I-DNA
O	O	888	892	with	with	B-PP	IN	O	35	NMOD	O
O	O	893	906	modifications	modification	B-NP	NNS	O	36	PMOD	O
O	O	907	909	in	in	B-PP	IN	O	37	NMOD	O
O	O	910	913	the	the	B-NP	DT	O	43	NMOD	O
O	O	914	916	NF	NF	I-NP	NN	B-protein	43	NMOD	B-protein
O	O	916	917	-	-	B-NP	HYPH	I-protein	43	NMOD	I-protein
O	O	917	922	kappa	kappa	I-NP	NN	I-protein	43	NMOD	I-protein
O	O	923	924	B	B	I-NP	NN	I-protein	45	NMOD	I-protein
O	O	925	928	and	and	O	CC	O	45	NMOD	O
O	O	928	929	/	/	B-NP	SYM	O	38	PMOD	O
O	O	929	931	or	or	O	CC	O	49	NMOD	O
T9	B-Protein	932	935	Sp1	Sp1	B-NP	NN	B-DNA	49	NMOD	B-DNA
T23	B-Entity	936	943	binding	binding	I-NP	NN	I-DNA	49	NMOD	I-DNA
T23	I-Entity	944	949	sites	site	I-NP	NNS	I-DNA	45	NMOD	I-DNA
O	O	949	950	.	.	O	.	O	7	P	O

O	O	951	953	In	In	B-PP	IN	O	6	VMOD	O
O	O	954	958	this	this	B-NP	DT	O	3	NMOD	O
O	O	959	964	study	study	I-NP	NN	O	1	PMOD	O
O	O	964	965	,	,	O	,	O	6	P	O
O	O	966	968	we	we	B-NP	PRP	O	6	SUB	O
O	O	969	973	show	show	B-VP	VBP	O	0	ROOT	O
O	O	974	978	that	that	B-SBAR	IN	O	6	VMOD	O
T10	B-Protein	979	982	Tat	Tat	B-NP	NN	B-protein	10	NMOD	B-protein
O	O	982	983	-	-	B-NP	HYPH	O	10	P	O
O	O	984	987	HIV	HIV	I-NP	NN	O	12	NMOD	O
O	O	987	988	-	-	B-NP	HYPH	O	12	P	O
O	O	988	989	1	1	I-NP	CD	O	18	SUB	O
O	O	990	994	with	with	B-PP	IN	O	12	NMOD	O
T24	B-Entity	995	999	wild	wild	B-NP	JJ	B-DNA	17	NMOD	B-DNA
T24	I-Entity	999	1000	-	-	I-NP	HYPH	I-DNA	17	NMOD	I-DNA
T24	I-Entity	1000	1004	type	type	I-NP	NN	I-DNA	17	NMOD	I-DNA
T24	I-Entity	1005	1009	LTRs	LTR	I-NP	NNS	I-DNA	13	PMOD	I-DNA
O	O	1010	1013	can	can	B-VP	MD	O	31	VMOD	O
O	O	1014	1023	replicate	replicate	I-VP	VB	O	18	VC	O
O	O	1024	1026	in	in	B-PP	IN	O	19	VMOD	O
O	O	1027	1031	HeLa	HeLa	B-NP	NN	B-cell_line	22	NMOD	B-cell_line
O	O	1032	1037	cells	cell	I-NP	NNS	I-cell_line	20	PMOD	I-cell_line
O	O	1037	1038	,	,	O	,	O	31	P	O
O	O	1039	1042	and	and	O	CC	O	31	VMOD	O
O	O	1043	1046	the	the	B-NP	DT	O	26	NMOD	O
O	O	1047	1052	virus	virus	I-NP	NN	O	31	SUB	O
O	O	1053	1061	produced	produce	B-VP	VBN	O	26	NMOD	O
O	O	1062	1066	from	from	B-PP	IN	O	27	VMOD	O
O	O	1067	1071	HeLa	HeLa	B-NP	NN	B-cell_line	30	NMOD	B-cell_line
O	O	1072	1077	cells	cell	I-NP	NNS	I-cell_line	28	PMOD	I-cell_line
O	O	1078	1081	can	can	B-VP	MD	O	7	SBAR	O
O	O	1082	1088	infect	infect	I-VP	VB	O	31	VC	O
O	O	1089	1096	primary	primary	B-NP	JJ	B-cell_type	38	NMOD	B-cell_type
O	O	1097	1107	peripheral	peripheral	I-NP	JJ	I-cell_type	36	NMOD	I-cell_type
O	O	1108	1113	blood	blood	I-NP	NN	I-cell_type	36	NMOD	I-cell_type
O	O	1114	1125	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	38	NMOD	I-cell_type
O	O	1126	1129	and	and	O	CC	O	38	NMOD	O
O	O	1130	1141	macrophages	macrophage	B-NP	NNS	B-cell_type	32	OBJ	B-cell_type
O	O	1141	1142	.	.	O	.	O	6	P	O

O	O	1143	1145	It	It	B-NP	PRP	O	2	SUB	O
O	O	1146	1149	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1150	1155	found	find	I-VP	VBN	O	2	VC	O
O	O	1156	1160	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	1161	1164	the	the	B-NP	DT	O	6	NMOD	O
O	O	1165	1176	propagation	propagation	I-NP	NN	O	16	SUB	O
O	O	1177	1179	of	of	B-PP	IN	O	6	NMOD	O
O	O	1180	1183	the	the	B-NP	DT	O	10	NMOD	O
T11	B-Protein	1184	1187	Tat	Tat	I-NP	NN	B-protein	10	NMOD	B-protein
O	O	1188	1195	mutants	mutant	I-NP	NNS	I-protein	7	PMOD	I-protein
O	O	1196	1206	containing	contain	B-VP	VBG	O	10	NMOD	O
T25	B-Entity	1207	1211	wild	wild	B-NP	JJ	B-DNA	15	NMOD	B-DNA
T25	I-Entity	1211	1212	-	-	I-NP	HYPH	I-DNA	15	NMOD	I-DNA
T25	I-Entity	1212	1216	type	type	I-NP	NN	I-DNA	15	NMOD	I-DNA
T25	I-Entity	1217	1221	LTRs	LTR	I-NP	NNS	I-DNA	11	OBJ	I-DNA
O	O	1222	1225	was	be	B-VP	VBD	O	4	SBAR	O
O	O	1226	1230	less	less	B-ADJP	RBR	O	18	AMOD	O
O	O	1231	1240	efficient	efficient	I-ADJP	JJ	O	16	PRD	O
O	O	1241	1245	than	than	B-PP	IN	O	18	AMOD	O
O	O	1246	1250	that	that	B-NP	DT	O	19	PMOD	O
O	O	1251	1253	of	of	B-PP	IN	O	20	NMOD	O
O	O	1254	1257	the	the	B-NP	DT	O	23	NMOD	O
O	O	1258	1261	LTR	LTR	I-NP	NN	B-DNA	27	NMOD	B-DNA
O	O	1261	1262	-	-	B-VP	HYPH	O	27	P	O
O	O	1262	1270	modified	modify	B-NP	VBN	O	27	NMOD	O
T12	B-Protein	1271	1274	Tat	Tat	I-NP	NN	B-protein	27	NMOD	B-protein
O	O	1275	1282	mutants	mutant	I-NP	NNS	I-protein	21	PMOD	I-protein
O	O	1282	1283	.	.	O	.	O	2	P	O

O	O	1284	1289	Large	Large	B-NP	JJ	O	2	NMOD	O
O	O	1290	1297	amounts	amount	I-NP	NNS	O	8	SUB	O
O	O	1298	1300	of	of	B-PP	IN	O	2	NMOD	O
O	O	1301	1306	viral	viral	B-NP	JJ	B-RNA	5	NMOD	B-RNA
O	O	1307	1310	RNA	RNA	I-NP	NN	I-RNA	7	NMOD	I-RNA
O	O	1311	1314	and	and	I-NP	CC	O	7	NMOD	O
O	O	1315	1324	particles	particle	I-NP	NNS	O	3	PMOD	O
O	O	1325	1329	were	be	B-VP	VBD	O	0	ROOT	O
O	O	1330	1341	synthesized	synthesize	I-VP	VBN	O	8	VC	O
O	O	1342	1344	in	in	B-PP	IN	O	9	VMOD	O
O	O	1345	1355	infections	infection	B-NP	NNS	O	10	PMOD	O
O	O	1356	1367	established	establish	B-VP	VBN	O	11	NMOD	O
O	O	1368	1373	using	use	B-VP	VBG	O	8	VMOD	O
O	O	1374	1377	the	the	B-NP	DT	O	16	NMOD	O
T13	B-Protein	1378	1381	tat	tat	I-NP	NN	B-protein	16	NMOD	B-protein
O	O	1382	1389	mutants	mutant	I-NP	NNS	I-protein	13	OBJ	I-protein
O	O	1390	1394	that	that	B-NP	WDT	O	16	NMOD	O
O	O	1395	1402	contain	contain	B-VP	VBP	O	17	SBAR	O
T26	B-Entity	1403	1411	modified	modify	B-NP	VBN	O	20	NMOD	O
T26	I-Entity	1412	1416	LTRs	LTR	I-NP	NNS	B-DNA	18	OBJ	B-DNA
O	O	1416	1417	.	.	O	.	O	8	P	O

O	O	1418	1425	However	However	B-ADVP	RB	O	13	VMOD	O
O	O	1425	1426	,	,	O	,	O	13	P	O
O	O	1427	1431	this	this	B-NP	DT	O	5	NMOD	O
O	O	1432	1441	efficient	efficient	I-NP	JJ	O	5	NMOD	O
O	O	1442	1453	propagation	propagation	I-NP	NN	O	13	SUB	O
O	O	1454	1456	of	of	B-PP	IN	O	5	NMOD	O
O	O	1457	1460	the	the	B-NP	DT	O	8	NMOD	O
T27	B-Entity	1461	1464	LTR	LTR	I-NP	NN	B-DNA	12	NMOD	B-DNA
O	O	1464	1465	-	-	B-VP	HYPH	O	12	NMOD	O
O	O	1465	1473	modified	modify	B-NP	VBN	O	12	NMOD	O
T14	B-Protein	1474	1477	tat	tat	I-NP	NN	B-protein	12	NMOD	B-protein
O	O	1478	1485	mutants	mutant	I-NP	NNS	I-protein	6	PMOD	I-protein
O	O	1486	1489	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1490	1500	restricted	restricted	B-ADJP	JJ	O	13	PRD	O
O	O	1501	1503	to	to	B-PP	TO	O	14	AMOD	O
O	O	1504	1508	some	some	B-NP	DT	O	19	NMOD	O
O	O	1509	1517	lymphoid	lymphoid	I-NP	JJ	B-cell_line	19	NMOD	B-cell_line
O	O	1518	1522	cell	cell	I-NP	NN	I-cell_line	19	NMOD	I-cell_line
O	O	1523	1528	lines	line	I-NP	NNS	I-cell_line	15	PMOD	I-cell_line
O	O	1529	1533	that	that	B-NP	WDT	O	19	NMOD	O
O	O	1534	1538	have	have	B-VP	VBP	O	20	SBAR	O
O	O	1539	1543	been	be	I-VP	VBN	O	21	VC	O
O	O	1544	1555	transformed	transform	I-VP	VBN	O	22	VC	O
O	O	1556	1560	with	with	B-PP	IN	O	23	VMOD	O
O	O	1561	1566	other	other	B-NP	JJ	O	26	NMOD	O
O	O	1567	1574	viruses	virus	I-NP	NNS	O	24	PMOD	O
O	O	1574	1575	.	.	O	.	O	13	P	O

O	O	1576	1580	Thus	Thus	B-ADVP	RB	O	14	VMOD	O
O	O	1580	1581	,	,	O	,	O	14	P	O
O	O	1582	1589	despite	despite	B-PP	IN	O	14	VMOD	O
O	O	1590	1593	its	its	B-NP	PRP$	O	6	NMOD	O
O	O	1594	1603	essential	essential	I-NP	JJ	O	6	NMOD	O
O	O	1604	1608	role	role	I-NP	NN	O	3	PMOD	O
O	O	1609	1612	for	for	B-PP	IN	O	6	NMOD	O
O	O	1613	1622	releasing	release	B-VP	VBG	O	7	PMOD	O
O	O	1623	1625	an	an	B-NP	DT	O	11	NMOD	O
O	O	1626	1636	elongation	elongation	I-NP	NN	B-protein	11	NMOD	B-protein
O	O	1637	1642	block	block	I-NP	NN	I-protein	8	OBJ	I-protein
O	O	1642	1643	,	,	O	,	O	14	P	O
T15	B-Protein	1644	1647	Tat	Tat	B-NP	NN	B-protein	14	SUB	B-protein
O	O	1648	1650	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	1651	1654	not	not	O	RB	O	14	VMOD	O
O	O	1655	1664	otherwise	otherwise	B-VP	RB	O	14	VMOD	O
O	O	1665	1675	absolutely	absolutely	I-VP	RB	O	14	VMOD	O
O	O	1676	1684	required	require	I-VP	VBN	O	14	VC	O
O	O	1685	1688	for	for	B-PP	IN	O	18	VMOD	O
O	O	1689	1698	synthesis	synthesis	B-NP	NN	O	28	NMOD	O
O	O	1699	1701	of	of	B-PP	IN	O	20	NMOD	O
O	O	1702	1706	full	full	B-NP	JJ	B-RNA	26	NMOD	B-RNA
O	O	1706	1707	-	-	I-NP	HYPH	I-RNA	26	P	I-RNA
O	O	1707	1713	length	length	I-NP	NN	I-RNA	26	NMOD	I-RNA
O	O	1714	1717	HIV	HIV	I-NP	NN	I-RNA	26	NMOD	I-RNA
O	O	1718	1729	transcripts	transcript	I-NP	NNS	I-RNA	21	PMOD	I-RNA
O	O	1730	1733	and	and	O	CC	O	28	NMOD	O
O	O	1734	1742	assembly	assembly	B-NP	NN	O	19	PMOD	O
O	O	1743	1745	of	of	B-PP	IN	O	28	NMOD	O
O	O	1746	1751	virus	virus	B-NP	NN	O	31	NMOD	O
O	O	1752	1761	particles	particle	I-NP	NNS	O	29	PMOD	O
O	O	1761	1762	.	.	O	.	O	14	P	O

O	O	1763	1769	Direct	Direct	B-NP	JJ	O	2	NMOD	O
O	O	1770	1780	sequencing	sequencing	I-NP	NN	O	9	NMOD	O
O	O	1781	1783	of	of	B-PP	IN	O	2	NMOD	O
O	O	1784	1787	the	the	B-NP	DT	O	6	NMOD	O
T28	B-Entity	1788	1793	viral	viral	I-NP	JJ	B-DNA	6	NMOD	B-DNA
T28	I-Entity	1794	1801	genomes	genome	I-NP	NNS	I-DNA	3	PMOD	I-DNA
O	O	1802	1805	and	and	O	CC	O	9	NMOD	O
O	O	1806	1817	reinfection	reinfection	B-NP	NN	O	9	NMOD	O
O	O	1818	1826	kinetics	kinetic	I-NP	NNS	O	10	SUB	O
O	O	1827	1833	showed	show	B-VP	VBD	O	0	ROOT	O
O	O	1834	1836	no	no	B-NP	DT	O	12	NMOD	O
O	O	1837	1845	evidence	evidence	I-NP	NN	O	10	OBJ	O
O	O	1846	1848	of	of	B-PP	IN	O	12	NMOD	O
O	O	1849	1853	wild	wild	B-NP	JJ	O	17	NMOD	O
O	O	1853	1854	-	-	I-NP	HYPH	O	17	NMOD	O
O	O	1854	1858	type	type	I-NP	NN	O	17	NMOD	O
O	O	1859	1868	reversion	reversion	I-NP	NN	O	13	PMOD	O
O	O	1869	1873	even	even	B-PP	RB	O	19	PMOD	O
O	O	1874	1879	after	after	I-PP	IN	O	10	VMOD	O
O	O	1880	1889	prolonged	prolonged	B-NP	JJ	O	21	NMOD	O
O	O	1890	1899	infection	infection	I-NP	NN	O	19	PMOD	O
O	O	1900	1904	with	with	B-PP	IN	O	21	NMOD	O
O	O	1905	1908	the	the	B-NP	DT	O	26	NMOD	O
T16	B-Protein	1909	1912	Tat	Tat	I-NP	NN	B-protein	26	NMOD	B-protein
O	O	1912	1913	-	-	B-NP	HYPH	O	26	NMOD	O
O	O	1914	1919	virus	virus	I-NP	NN	O	22	PMOD	O
O	O	1919	1920	.	.	O	.	O	10	P	O

O	O	1921	1924	The	The	B-NP	DT	O	2	NMOD	O
O	O	1925	1937	implications	implication	I-NP	NNS	O	23	SUB	O
O	O	1938	1941	for	for	B-PP	IN	O	2	NMOD	O
O	O	1942	1944	in	in	B-NP	FW	O	5	AMOD	O
O	O	1945	1949	vivo	vivo	I-NP	FW	O	6	NMOD	O
O	O	1950	1953	HIV	HIV	I-NP	NN	O	12	NMOD	O
O	O	1953	1954	-	-	B-NP	HYPH	O	9	NMOD	O
O	O	1954	1955	1	1	I-NP	CD	O	9	NMOD	O
O	O	1956	1967	replication	replication	I-NP	NN	O	6	NMOD	O
O	O	1968	1971	and	and	I-NP	CC	O	12	NMOD	O
O	O	1972	1981	potential	potential	I-NP	JJ	O	12	NMOD	O
O	O	1982	1993	application	application	I-NP	NN	O	3	PMOD	O
O	O	1994	1996	of	of	B-PP	IN	O	12	NMOD	O
O	O	1997	2001	this	this	B-NP	DT	O	15	NMOD	O
O	O	2002	2008	system	system	I-NP	NN	O	13	PMOD	O
O	O	2009	2011	to	to	B-PP	TO	O	12	NMOD	O
O	O	2012	2015	the	the	B-NP	DT	O	18	NMOD	O
O	O	2016	2021	study	study	I-NP	NN	O	16	PMOD	O
O	O	2022	2024	of	of	B-PP	IN	O	18	NMOD	O
O	O	2025	2036	alternative	alternative	B-NP	JJ	O	22	NMOD	O
T17	B-Protein	2037	2040	Tat	Tat	I-NP	NN	B-protein	22	NMOD	B-protein
O	O	2041	2049	function	function	I-NP	NN	O	19	PMOD	O
O	O	2050	2053	are	be	B-VP	VBP	O	0	ROOT	O
O	O	2054	2063	discussed	discuss	I-VP	VBN	O	23	VC	O
O	O	2063	2064	.	.	O	.	O	23	P	O
